# Brineura

NDC: 68135-811
Generic name: cerliponase alfa
Labeler / Manufacturer: BioMarin Pharmaceutical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20170427

FDA application: BLA761052

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68135-811"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68135-811
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=485ab3c5-0359-4878-872f-2fe1e7df4047